-
Inhaled Carrier May Safely Deliver Therapeutics to Lungs of Patients with CF
An inhaled form of messenger RNA (mRNA) with the potential to safely deliver therapeutics to the lungs of cystic fibrosis (CF) patients has been discovered by researchers at the Massachusetts Institute of Technology (MIT).
Researchers developed a type of nanoparticle given as an inhaled mist (nebulizer) that allows the delivery of mRNAs to the lungs of mice. This kind of carrier may be used to administer mRNA therapeutics directly to the lungs of people with CF and other lung diseases, researchers say.
Do you use an inhaled carrier like this to treat your CF?
-
0 Replies
Sorry, there were no replies found.
Log in to reply.